Hubbard Cristin 4

What Happened

• Cristin Hubbard, EVP and Chief Commercial Officer of BioMarin (BMRN), received equity awards on March 16, 2026: 15,410 restricted stock units (RSUs) and a derivative award covering 36,680 shares (option/award). On March 17, 2026, 1,245 shares were disposed (withheld) to satisfy tax obligations at $56.05 per share, totaling approximately $69,782. The awards were reported on a Form 4 filed March 18, 2026.

Key Details

• Transaction dates and amounts:
  • Mar 16, 2026: Award of 15,410 RSUs (price N/A).
  • Mar 16, 2026: Award/derivative grant of 36,680 shares (price N/A for grant).
  • Mar 17, 2026: 1,245 shares withheld/disposed to cover tax liability at $56.05 each = $69,782.
• Shares owned after transaction: Not specified in the data you provided.
• Footnotes:
  • F1: Restricted stock units granted March 16, 2026 (price not applicable).
  • F2: Option/award vests 12/48th on March 16, 2027 and then 1/48th monthly thereafter.
• Filing timeliness: Form 4 filed March 18, 2026 for a March 16 transaction — filed within the normal 2-business-day window.

Context

• The 1,245-share disposal was a tax-withholding event (code F), a routine administrative action when RSUs vest; it is not an open-market sale and generally does not indicate a proactive bearish view. The larger item of interest is the grant of RSUs and a time‑vested derivative award (option-like) with a multi-year vesting schedule.